key: cord-0324218-r5eldmlg authors: Kumar, Ram; Chander, Yogesh; Khandelwal, Nitin; Nagori, Himanshu; Verma, Assim; Pal, Yash; Gulati, Baldev R.; Tripathi, Bhupendra N.; Barua, Sanjay; Kumar, Naveen title: hnRNPA1 regulates early translation to replication switch in SARS-CoV-2 life cycle date: 2021-07-14 journal: bioRxiv DOI: 10.1101/2021.07.13.452288 sha: f0a5945f40de8930898d6f770372225d83336a6f doc_id: 324218 cord_uid: r5eldmlg Our study suggests that methylation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA is essential for its optimal replication in the target cells. Heterogeneous nuclear ribonucleoprotein A1 (hnRNPA1, an RNA-binding protein) was shown to mediate deposition of N6-methyladenosine (m6A) in internal SARS-CoV-2 RNA. The levels of hNRNPA1 expression and extent of methylation varied, depending on the course of SARS-CoV-2 life cycle. The recruitment of eIF4E (translational initiation factor) facilitated viral RNA translation at 1 hour post infection (1 hpi). However, at 2 hpi, methylation of internal SARS-CoV-2 RNA recruited hNRNPA1 which facilitated viral RNA transcription but resulted in translational repression, a phenomenon contributing in understanding the early translation to replication switch in the viral life cycle. Besides, the abrogation of methylation also produced a defective 5’ cap of viral RNA which failed to interact with eIF4E, thereby resulting in a decreased synthesis of viral proteins. To conclude, methylation of the internal and 5’ cap of SARS-CoV-2 RNA was shown to regulate transcription and translation of SARS-CoV-2 in a time dependent manner. IMPORTANCE RNA modifications are found in all life forms and have been linked to development, health and diseases. Our study reveals that internal SARS-CoV-2 RNA methylation (m6A) is essential for interaction with hNRNPA1 to effectively synthesize viral genome. Besides, m6A-marked RNA and hRNPA1 interaction was also shown to regulate early translation to replication switch in SARS-CoV-2 life cycle. Blocking SARS-CoV-2 RNA methylation resulted in reduced virus yield, suggesting epitranscriptomic machinery (methylation) facilitates SARS-CoV-2 replication and might represent potential target for new antiviral drugs against COVID-19. in the RNA-binding protein database (RBPDB) 166 (http://rbpdb.ccbr.utoronto.ca/). Out of the 11 m6A readers known (24), in silico 167 binding with the SARS-CoV-2 genome could be predicted with only hnRNPA1 and 168 YTHDC1. The hnRNPA1 was predicted to bind in the 3'-end (two sites) and "S" gene 169 (one site) of the SARS-CoV-2 genome with a position weight matrix score of >9.89 170 ( Table S1 ). The YTHDC1 was predicted to interact at multiple sites in each gene We observed a switch on/off phenomenon in the hRNPA1 expression levels in Epitranscriptomic regulation 516 by m(6)A RNA methylation in brain development and diseases Mechanisms of epitranscriptomic gene 519 regulation MODOMICS: An Operational Guide to the 521 Use of the RNA Modification Pathways Database methyltransferases modify tRNA and mRNA in mice and humans 621 2016. m(6)A-LAIC-seq reveals the census and complexity of the m(6)A 622 epitranscriptome methyladenosine RNA modification status at single nucleotide resolution in 625 mRNA and long noncoding RNA Epitranscriptomic Code and Its Alterations in Emetine inhibits replication 713 of RNA and DNA viruses without generating drug-resistant virus variants The importin-alpha/nucleophosmin switch controls taspase1 protease 719 function An eIF4E-interacting peptide induces cell death 722 in cancer cell lines mRNA decapping in yeast requires 724 dissociation of the cap binding protein, eukaryotic translation initiation factor 725 4E Purifying mRNAs with a high-affinity eIF4E 727 mutant identifies the short 3′ poly (A) end phenotype CLIP: crosslinking and immunoprecipitation of 730 in vivo RNA targets of RNA-binding proteins Methods to study RNA-736 protein interactions The Xist lncRNA 739 interacts directly with SHARP to silence transcription through HDAC3 REAP: to immunoprecipitate the RNA. The amount of SARS-CoV-2 RNA in the